These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 13712856)

  • 1. [On quantitative differences in the effect between 1-isonicotinoyl-2-isopropyl hydrazine (iproniazid) and isopropyl hydrazine on monoamine oxidase].
    HEIM F; DIEMER K
    Med Exp Int J Exp Med; 1960; 3():249-51. PubMed ID: 13712856
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835).
    SPECTOR S; SHORE PA; BRODIE BB
    J Pharmacol Exp Ther; 1960 Jan; 128():15-21. PubMed ID: 13833205
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of diamine oxidase in vivo by hydrazine derivatives.
    BURKARD WP; GEY KF; PLETSCHER A
    Biochem Pharmacol; 1960 Jul; 3():249-55. PubMed ID: 13806127
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental pathology of iproniazid and related compounds.
    ZBINDEN G; STUDER A
    Ann N Y Acad Sci; 1959 Sep; 80():873-84. PubMed ID: 13847126
    [No Abstract]   [Full Text] [Related]  

  • 5. [The influence of iproniazid and beta-phenylisopropylhydrazine (JB516) on the narcotic effect and decomposition of hexobarbital and thiopental].
    ARRIGONI-MARTELLI E; KRAMER M
    Med Exp Int J Exp Med; 1959; 1():45-51. PubMed ID: 13794503
    [No Abstract]   [Full Text] [Related]  

  • 6. Histochemical demonstration in rat of monoamine oxidase inhibition of beta-phenyl-isopropyl hydrazine.
    MUSTAKALLIO KK; LEVONEN E; RAEKALLIO J
    Science; 1961 Aug; 134(3475):344. PubMed ID: 13727138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On the adrenergic action of iproniazid, inhibitor of monoamine oxidase].
    MEYER F
    C R Hebd Seances Acad Sci; 1961 Apr; 252():2616-8. PubMed ID: 13769974
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on monoamine oxidase. 2: p-Methylphenyl hydrazine, a potent and selective monoamine oxidase inhibitor.
    ARAI A
    Jpn J Pharmacol; 1960 Mar; 9():159-68. PubMed ID: 13683948
    [No Abstract]   [Full Text] [Related]  

  • 9. The route of administration of some hydrazine compounds as a determinant of brain and liver monoamine oxidase inhibition.
    HORITA A
    Toxicol Appl Pharmacol; 1961 Jul; 3():474-80. PubMed ID: 13715854
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the active center of monoamine oxidase.
    ZELLER EA
    Experientia; 1960 Sep; 16():399-402. PubMed ID: 13788171
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparative trial of four monoamine oxidase inhibitors on chronic depressives.
    BATES TJ; DOUGLAS AD
    J Ment Sci; 1961 May; 107():538-46. PubMed ID: 13687739
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of iproniazid and similar compounds on the gastrointestinal tract.
    WEISS J; WEISS S; WEISS B
    Ann N Y Acad Sci; 1959 Sep; 80():854-9. PubMed ID: 13843720
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of iproniazid with other amine oxidase inhibitors, including W-1544, JB-516, RO 4-1018, and RO 5-0700.
    BAILEY SD; BUCCI L; GOSLINE E; KLINE NS; PARK IH; ROCHLIN D; SAUNDERS JC; VAISBERG M
    Ann N Y Acad Sci; 1959 Sep; 80():652-68. PubMed ID: 13795859
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacological properties of a new inhibitor of monoamine oxidase: 2-hydrazino-1-phenylpropane].
    GENOVESE E; ARRIGONI-MARTELLI E; FRESIA P
    Farmaco Sci; 1959 Jul; 14():516-26. PubMed ID: 13849925
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversal of the reserpine-induced depletion of brain serotonin by a monoamine oxidase inhibitor.
    CANAL N; MAFFEI-FACCIOLI A
    J Neurochem; 1959 Dec; 5():99-100. PubMed ID: 13807360
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of monoamine oxidase inhibitors of various chemical nature on some indices of carbohydrate metabolism in the rabbit brain].
    Musialkovskaia AA
    Ukr Biokhim Zh; 1967; 39(2):119-24. PubMed ID: 5603054
    [No Abstract]   [Full Text] [Related]  

  • 17. In vivo monoamine oxidase inhibition measured by potentiation of tryptamine convulsions in rats.
    TEDESCHI DH; TEDESCHI RE; FELLOWS EJ
    Proc Soc Exp Biol Med; 1960 Apr; 103():680-2. PubMed ID: 13837257
    [No Abstract]   [Full Text] [Related]  

  • 18. Monoamine oxidase inhibitor reversal of parathion extension of hexobarbital action.
    Proctor CD
    Arch Int Pharmacodyn Ther; 1965 Apr; 154(2):468-73. PubMed ID: 4378733
    [No Abstract]   [Full Text] [Related]  

  • 19. Theoretic background of therapy with monoamine oxidase inhibitors in cardiology.
    ZBINDEN G
    Am J Cardiol; 1960 Dec; 6():1121-4. PubMed ID: 13788034
    [No Abstract]   [Full Text] [Related]  

  • 20. [Research on the benzodioxan series. XIX. Hydrazine derivatives of 1, 4-benzodioxan. Synthesis and pharmacological properties].
    MARINI-BETTOLO GB; LANDI VITTORY R; JORIO MA; BOVET-NITTI F; ORSINGHER O
    Rend Ist Sup Sanit; 1960; 23():1110-27. PubMed ID: 13766823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.